Vascular Biogenics Ltd. - Ordinary Shares (VBLT): Price and Financial Metrics

Vascular Biogenics Ltd. - Ordinary Shares (VBLT): $5.46

0.53 (-8.77%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add VBLT to Watchlist
Sign Up

VBLT Price/Volume Stats

Current price $5.46 52-week high $6.74
Prev. close $0.17 52-week low $0.10
Day low $5.34 Volume 161,505
Day high $6.74 Avg. volume 2,187,886
50-day MA $0.23 Dividend yield N/A
200-day MA $0.20 Market Cap 423.91M

VBLT Stock Price Chart Interactive Chart >


Vascular Biogenics Ltd. - Ordinary Shares (VBLT) Company Bio


Vascular Biogenics Limited is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases. The company was founded in 2000 and is based in Or Yehuda, Israel.


VBLT Latest News Stream


Event/Time News Detail
Loading, please wait...

VBLT Latest Social Stream


Loading social stream, please wait...

View Full VBLT Social Stream

Latest VBLT News From Around the Web

Below are the latest news stories about VASCULAR BIOGENICS LTD that investors may wish to consider to help them evaluate VBLT as an investment opportunity.

Notable Labs Closes Merger Transaction With VBL Therapeutics

- Notable expects to initiate trading on the Nasdaq Capital Market under ticker symbol “NTBL” effective at market open on October 17 - - Aggregate net transaction proceeds expected to fund planned operations into 2025 - - Completed previously announced $10.3 million private placement with leading healthtech-focused investors, led by Builders VC, B Capital Group, Y Combinator, First Round Capital, and Founders Fund - - Predictive Precision Medicines Platform (“PPMP”) applied to select and develop

Yahoo | October 16, 2023

VBL Therapeutics Announces Results of Annual and Special Shareholder Meeting

Approved Merger with Notable Labs and All Other Proposals Merger Expected to Close and Begin Trading as Combined Company Under the NTBL Ticker on Nasdaq Next Week, Subject to Effectiveness of Approved Israeli Corporate Actions MODI’IN, Israel and NEW YORK, Oct. 12, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (“VBL”), today announced that its shareholders voted to approve the previously announced proposed merger (the “Merger”) with Notable Labs, Inc. (“Notable”), at the annual and sp

Yahoo | October 12, 2023

VBL Therapeutics Reminds Shareholders to Vote in the Upcoming Annual and Special Shareholder Meeting

Shareholders of record as of September 5, 2023 are eligible to vote at the VBL Shareholder Meeting on October 12, 2023MODI’IN, Israel and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (“VBL”), reminds its shareholders to vote in favor of the previously announced proposed merger (the “Merger”) with Notable Labs (“Notable”) at the annual and special meeting (the “Meeting”) for shareholders of record as of September 5, 2023. All VBL shareholders, regardless of number o

Yahoo | October 4, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start the day with a breakdown of the biggest pre-market stock movers that traders will want to watch on Thursday!

William White on InvestorPlace | September 21, 2023

VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC

Merger with Notable expected to close in mid-October, subject to shareholder approval Special shareholder meeting scheduled for October 12, 2023 MODI’IN, Israel and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (“VBL”), today announced that its registration statement on Form S-4 in connection with the proposed merger with Notable Labs, Inc. (“Notable”) has been declared effective by the U.S. Securities and Exchange Commission (“SEC”). The definitive merger agreemen

Yahoo | September 6, 2023

Read More 'VBLT' Stories Here

VBLT Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year -35.80%
3-year -93.98%
5-year -87.00%
YTD N/A
2023 0.00%
2022 -93.91%
2021 4.23%
2020 57.50%
2019 23.71%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!